Market Cap (In EUR)
74.6 Million
Revenue (In EUR)
77.06 Million
Net Income (In EUR)
-1.86 Million
Avg. Volume
928.00
- Currency
- EUR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3.69-5.9
- PE
- -
- EPS
- -
- Beta Value
- 0.622
- ISIN
- DE000A0BL849
- CUSIP
- D9506F102
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Mr. Jakub Julian Baran
- Employee Count
- -
- Website
- https://www.vita34.de
- Ipo Date
- 2007-03-27
- Details
- VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. It also develops cell therapeutic procedures; cell and gene therapies; cryopreservation of endogenous immune cells; and CAR-T. In addition, the company manufactures advanced therapy medicinal products based on mesenchymal stem cells for experimental treatment by specialized medical institutions; preserves stem cells from perinatal tissue and adult body fat; and engages in the contract manufacturing of pharmaceutical intermediates. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.
More Stocks
-
KN
-
DNGDFDynacor Group Inc.
DNGDF
-
1171
-
PTPIF
-
SATLWSatellogic Inc.
SATLW
-
AU1
-
CSL
-
LSDAFLassonde Industries Inc.
LSDAF